J.P. Morgan reduces its stake in SINOPHARM (01099) by approximately 1.22 million shares, with a price of around HK$19.87 per share.
On February 18, J.P. Morgan reduced its holdings in China National Pharmaceutical Group Corporation (01099) by 1,221,708 shares, with each share priced at HK$19.8733.
According to the latest data from the Hong Kong Stock Exchange, on February 18th, J.P. Morgan reduced its holdings of SINOPHARM (01099) by 1,221,708 shares, with an average price of HK$19.8733 per share, for a total amount of approximately HK$24.2794 million. After the reduction, the latest number of shares held is approximately 107 million shares, and the latest shareholding ratio is 7.96%.
RECOMMEND
Trump Signals End to Trade Talks, Vows to Impose Tariffs Unilaterally Ahead of July 9 Deadline
30/06/2025
One License Unlocks HKD 23.4 Billion Surge: Unpacking Hong Kong’s Ambitions as a Global Virtual Asset Hub
30/06/2025
16 Companies Submit IPO Applications in One Day; Hong Kong IPO Fundraising Hits Three-Year High
30/06/2025
